Journal: Kidney Medicine
Article Title: Metabolic Acidosis and Cardiovascular Disease in CKD
doi: 10.1016/j.xkme.2021.04.011
Figure Lengend Snippet: Study cohort selection diagram. MACE+ analysis group and cardiovascular death analysis group: n = 51,558; complete data, n = 36,917. Incident HF analysis group: n = 41,529, with 10,029 excluded; complete data, n = 28,817. Stroke analysis group: n = 47,103, with 4,455 excluded; complete data, n = 33,325. MI analysis group: n = 48,789, with 2,769 excluded; complete data, n = 34,573. Abbreviations: AKI, acute kidney injury; BL, baseline; CKD, chronic kidney disease; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; CV, cardiovascular; eGFR, estimated glomerular filtration rate; EHR, electronic health record; HF, heart failure; MACE+, major adverse cardiovascular event, defined as any MI, any stroke, incident HF (a new HF diagnosis in a patient without HF at baseline), or HF admission (an inpatient admission with a concurrent diagnosis of HF in a patient with comorbid HF at baseline), or cardiovascular death (death within the same or next calendar month as discharge from an inpatient hospital stay involving a diagnosis code for HF, stroke, or MI); MI, myocardial infarction.
Article Snippet: Data from January 1, 2007, to March 31, 2017, was extracted from the Optum EHR+Integrated Electronic Health Record (EHR) dataset, which is deidentified in compliance with the Health Insurance Portability and Accountability Act (HIPAA).
Techniques: Selection, Filtration, Biomarker Discovery